Cidara Therapeutics
Presence
Cidara Therapeutics is a company listed under the stock ticker CDTX (US).
Executives
View the org chart displaying its 15 main executives
Most searched biographies at Cidara Therapeutics
- Jeffrey Stein, Director, President and Chief Executive Officer
- David Gollaher, Director
- Timothy Franson, Director
Popular executive movements at Cidara Therapeutics
- Nicole Davarpanah has joined the company as Senior Vice President of Translational Research & Development (posted on August 17 2023).
Create your alert
to follow the executive moves at Cidara Therapeutics.
Biotechnology
Cidara Therapeutics has 2,282 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
- Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
- Histogen has filed for bankruptcy protection (posted on April 19 2024).
Popular contacts in Biotechnology
News
Press releases by Cidara Therapeutics
- Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results - Cidara Therapeutics
- Cidara Therapeutics Announces Reverse Stock Split - Cidara Therapeutics
- Cidara Therapeutics Announces Receipt of Nasdaq Delinquency Notice - Cidara Therapeutics
- Cidara Therapeutics Presents Promising New Data on Novel Drug-Fc Conjugate Candidates at the American Association for Cancer Research (AACR) Annual Meeting 2024 - Cidara Therapeutics
- Cidara Therapeutics to Present Preclincal Data on Multiple Novel Drug-Fc Conjugate Candidates at American Association for Cancer Research (AACR) Annual Meeting 2024 - Cidara Therapeutics
- Cidara Therapeutics Receives $11.14 Million Milestone Payment Following European Approval of REZZAYO - Cidara Therapeutics
- Cidara Therapeutics Announces Approval of REZZAYO by the MHRA for the Treatment of Invasive Candidiasis in Adults - Cidara Therapeutics
- Cidara Therapeutics Announces European Approval of REZZAYO® (rezafungin) for the Treatment of Invasive Candidiasis in Adults - Cidara Therapeutics
- Cidara Therapeutics Announces Completion of Enrollment in Phase 3 Restore Trial of Rezafungin in China - Cidara Therapeutics
- Cidara Therapeutics Presents New Promising Preclincal Data on Novel Dual-Acting Drug-Fc Conjugates at ESMO Immuno-Oncology Annual Congress - Cidara Therapeutics
- View more press releases Close
Social media about Cidara Therapeutics
- Cidara Therapeutics on Wikipedia, Google News & Yahoo Finance
- Cidara Therapeutics on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Jeffrey Stein 
Call Cidara Therapeutics at +1 858...
